tesaglitazar
Sign in to saveTesaglitazar (also known as AZ 242) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.
Chemical data
- Formula
- C20H24O7S
- Molecular weight
- 408.5 g/mol
- IUPAC name
- (2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
via PubChem
Article
1 sectionsContents
- References
Tesaglitazar (also known as AZ 242) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, proposed for the management of type 2 diabetes.
The drug had completed several phase III clinical trials, however in May, 2006 AstraZeneca announced that it had discontinued further development.
Connections
Categories
Abandoned drugsBenzosulfonesCarboxylic acidsChemical pages without DrugBank identifierDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs not assigned an ATC codeDrugs with non-standard legal statusECHA InfoCard ID from WikidataEthoxy compoundsPhenol ethersPPAR agonists